Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness
- PMID: 16961418
Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness
Abstract
The co-occurrence of a severe mental illness and a substance use or abuse disorder is common in the United States as well as internationally and could be considered as more the expectation than the exception when assessing patients with serious mental illness. Substance use disorders can occur at any phase of the mental illness, perhaps even inducing psychosis. Causes of this comorbidity may include self-medication, genetic vulnerability, environment or lifestyle, underlying shared origins, and/or a common neural substrate. The consequences of dual diagnosis include poor medication compliance, physical comorbidities and poor health, poor self-care, increased suicide risk or aggression, increased sexual behavior, and possible incarceration. All of these factors contribute to a greater health burden, which reduces the health care system's capacity to adequately treat patients. Therefore, screening, assessment, and integrated treatment plans for dual diagnosis that can address both the addiction disorder and the mental illness are recommended in order to provide accurate treatment, after-care, and other health care to accommodate patients' social and vocational needs.
Similar articles
-
Behavioral interventions for dual-diagnosis patients.Psychiatr Clin North Am. 2004 Dec;27(4):709-25. doi: 10.1016/j.psc.2004.07.002. Psychiatr Clin North Am. 2004. PMID: 15550289 Review.
-
Prevalence and consequences of dual diagnosis.J Clin Psychiatry. 2006 Jul;67(7):e01. doi: 10.4088/jcp.0706e01. J Clin Psychiatry. 2006. PMID: 17107226 Review.
-
Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.J Clin Psychiatry. 2006;67 Suppl 7:10-7. J Clin Psychiatry. 2006. PMID: 16961419 Review.
-
Mental illness and substance use: an Australian perspective.Int J Ment Health Nurs. 2008 Aug;17(4):255-60. doi: 10.1111/j.1447-0349.2008.00541.x. Int J Ment Health Nurs. 2008. PMID: 18666908 Review.
-
A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.Arch Gen Psychiatry. 2006 Apr;63(4):426-32. doi: 10.1001/archpsyc.63.4.426. Arch Gen Psychiatry. 2006. PMID: 16585472 Clinical Trial.
Cited by
-
Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.Schizophr Res. 2019 Apr;206:333-346. doi: 10.1016/j.schres.2018.10.022. Epub 2018 Oct 26. Schizophr Res. 2019. PMID: 30482645 Free PMC article.
-
Dropout Rates in Psychosocial Interventions for People With Both Severe Mental Illness and Substance Misuse: A Systematic Review and Meta-Analysis.Front Psychiatry. 2022 May 12;13:842329. doi: 10.3389/fpsyt.2022.842329. eCollection 2022. Front Psychiatry. 2022. PMID: 35633799 Free PMC article.
-
Service use and barriers to mental health care among adults with major depression and comorbid substance dependence.Psychiatr Serv. 2013 Sep 1;64(9):863-70. doi: 10.1176/appi.ps.201200289. Psychiatr Serv. 2013. PMID: 23728427 Free PMC article.
-
Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings.Hum Genet. 2012 Jun;131(6):877-901. doi: 10.1007/s00439-011-1122-6. Epub 2011 Dec 22. Hum Genet. 2012. PMID: 22190153 Free PMC article. Review.
-
Predictors of Mental Health Treatment Seeking and Engagement in a Community Mental Health Center.Community Ment Health J. 2017 Jul;53(5):510-514. doi: 10.1007/s10597-016-0062-y. Epub 2017 Feb 1. Community Ment Health J. 2017. PMID: 28150080
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical